Bruker (BRKR) Non Operating Income (2012 - 2026)
Bruker's (BRKR) quarterly Non Operating Income came in at $24.6 million in Q2 2026, up 315.79% on a YoY basis from $5.9 million in Q2 2025, and up 110.26% quarter-over-quarter from $11.7 million in Q1 2026.
Analysis
Bruker (BRKR) Non Operating Income (2012 - 2026) Analysis & Trends
Bruker (BRKR) has reported Non Operating Income for 15 consecutive years, with $24.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Income rose 315.79% year-over-year to $24.6 million; the trailing twelve-month figure through Jun 2026 stood at $8.2 million (up 117.48% YoY), and the FY2025 full-year result was -$46.2 million, changed 0.0% from the prior year.
- Non Operating Income advanced to $24.6 million in Q2 2026 per BRKR's latest filing, from $11.7 million in the prior quarter.
- Across five years, Non Operating Income topped out at $137.4 million in Q4 2023 and bottomed at -$24.2 million in Q2 2024.
- Historically, Non Operating Income has averaged $1.8 million across 5 years, with a median of -$7.4 million in 2025.
- The widest YoY moves for Non Operating Income: up 1474.0% in 2023, down 544.0% in 2023.
- Over 5 years, Non Operating Income stood at -$10.0 million in 2022, then jumped by 1474.0% to $137.4 million in 2023, then sank by 111.64% to -$16.0 million in 2024, then jumped by 49.38% to -$8.1 million in 2025, then surged by 403.7% to $24.6 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $24.6 million, $11.7 million, and -$8.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.86 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.28 Bn | 139.93 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.97 Bn | 39.21 Bn | 1.04 Bn | - |
| 4 | Illumina | 31.40 Bn | 30.23 Bn | 770.00 Mn | 15.00 Mn |
| 5 | Revvity | 13.71 Bn | 12.68 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -3.60 Mn |
| 7 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.47 Bn | 8.46 Bn | 110.04 Mn | 177,000.00 |
| 9 | 10x Genomics | 8.71 Bn | 8.16 Bn | 112.50 Mn | 910,000.00 |
| 10 | Bruker | 8.37 Bn | 8.16 Bn | 416.00 Mn | 24.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.60 Mn |
| Mar 31, 2026 | 11.70 Mn |
| Dec 31, 2025 | -8.10 Mn |
| Sep 30, 2025 | -20.00 Mn |
| Jun 30, 2025 | -11.40 Mn |
| Mar 31, 2025 | -6.70 Mn |
| Dec 31, 2024 | -16.00 Mn |
| Sep 30, 2024 | -12.80 Mn |
| Jun 30, 2024 | -24.20 Mn |
| Mar 31, 2024 | 6.80 Mn |
| Dec 31, 2023 | 137.40 Mn |
| Sep 30, 2023 | -5.30 Mn |
| Jun 30, 2023 | -8.70 Mn |
| Mar 31, 2023 | -16.10 Mn |
| Dec 31, 2022 | -10.00 Mn |
| Sep 30, 2022 | -2.00 Mn |
| Jun 30, 2022 | -4.30 Mn |
| Mar 31, 2022 | -2.50 Mn |
| Dec 31, 2021 | -5.90 Mn |
| Sep 30, 2021 | -4.40 Mn |